CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 150 enrolled
Drug / intervention
Gabapentin 900mg +3 moredrug
Likely dose
Gabapentin 900mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00391716
NCT00391716Phase 2Completed
CompareCT.gov

Gabapentin Treatment of Alcohol Dependence

The Scripps Research Institute·interventional·Posted Oct 24, 2006·Updated Nov 10, 2014

In Brief

A Phase 2 clinical trial evaluating Gabapentin 900mg, behavioral counseling, and 2 other interventions for Alcoholism and Alcohol Dependence. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Gabapentin treatment for alcohol dependence

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism, Alcohol Dependence
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 24, 2006
Enrollment StartFeb 1, 2004
Primary CompletionJul 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 19.7 years ago

Interventions

Gabapentin 900mgdrug

900 mg gabapentin daily for 12 weeks

behavioral counselingbehavioral

The manual for standardized alcohol-related behavioral counseling was developed by Drs. Barbara Mason and Anita Goodman. The manual is available at alcoholfree.info.

placebodrug

lactose capsule compounded to mimic gabapentin capsules

gabapentin 1800mgdrug

1800 mg gabapentin daily for 12 weeks